021-51111890
购物车（）
sales@molnova.cn
CA-5f
CAS No. 1370032-19-1
CA-5f ( —— )
产品货号. M19958 CAS No. 1370032-19-1
CA-5f 是一种有效的晚期巨自噬/自噬抑制剂，通过抑制自噬体-溶酶体融合。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥721 | 有现货 |
|
| 10MG | ￥1191 | 有现货 |
|
| 25MG | ￥2535 | 有现货 |
|
| 50MG | ￥4560 | 有现货 |
|
| 100MG | ￥6423 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CA-5f
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述CA-5f 是一种有效的晚期巨自噬/自噬抑制剂，通过抑制自噬体-溶酶体融合。
-
产品描述CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
-
体外实验Cell Viability Assay Cell Line:A549, HUVECs Concentration:20 μM Incubation Time:96 hours Result:Exhibited more cytotoxicity against A549 cells compared with normal HUVECs.Western Blot Analysis Cell Line:A549 cells and HUVECs Concentration:0-40 μM Incubation Time:6 hours Result:Elevated LC3B-II (a marker to monitor autophagy) and SQSTM1 protein levels in a concentration- and time-dependent manner.
-
体内实验Animal Model:Nude mice bearing A549 lung cancer cellsDosage:40 mg/kg Administration:Injected via caudal vein, every 2 days for up to 30 days Result:Significantly suppressed tumor volume and weight in mice, increased the number of apoptotic cells in mice.
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体Autophagy
-
研究领域——
-
适应症——
化学信息
-
CAS Number1370032-19-1
-
分子量388.46
-
分子式C24H24N2O3
-
纯度>98% (HPLC)
-
溶解度DMSO: 70 mg/mL;Water: Insoluble
-
SMILESCOc1ccc(\C=C2/CN(C)C\C(=C/c3c[nH]c4ccccc34)C2=O)cc1OC
-
化学全称(3E5E)-3-(34-dimethoxybenzylidene)-5-[(1H-indol-3-yl)methylene]-1-methylpiperidin-4-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zhang L et al. Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer. Autophagy. 2019 Mar;15(3):391-406.
产品手册
关联产品
-
Nilotinib hydrochlor...
Nilotinib (AMN107) hydrochloride 是一种口服可用的具有抗肿瘤活性的 Bcr-Abl 酪氨酸激酶抑制，可用于慢性骨髓性白血病的研究。
-
Gepotidacin mesylate...
Gepotidacin mesylate dihydrate (GSK2140944 mesylate dihydrate) is an orally available triazaacenaphthylene antibiotic with antibacterial activity. Gepotidacin mesylate dihydrate is an inhibitor of bacterial type II topoisomerase. Gepotidacin mesylate dihydrate inhibits bacterial DNA replication by blocking topoisomerase and can be used to study bacterial infection.
-
K-Ras(G12C) inhibito...
K-Ras(G12C) 抑制剂 9 是致癌 K-Ras(G12C) 的变构抑制剂。
